DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Symbyax (Olanzapine / Fluoxetine) - Completed Suicide - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Completed Suicide (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Symbyax (Olanzapine / Fluoxetine) where reactions include completed suicide. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Symbyax side effects in 7 year old male

Reported by a consumer/non-health professional from United States on 2011-11-21

Patient: 7 year old male, weighing 30.4 kg (66.8 pounds)

Reactions: Off Label Use, Completed Suicide, Anger, Self Injurious Behaviour, Fall

Adverse event resulted in: death

Drug(s) suspected as cause:
Symbyax

Other drugs received by patient: Lexapro; Vyvanse



Possible Symbyax side effects in 60 year old male

Reported by a consumer/non-health professional from Mexico on 2011-11-18

Patient: 60 year old male

Reactions: Completed Suicide

Adverse event resulted in: death

Drug(s) suspected as cause:
Symbyax



Possible Symbyax side effects in 7 year old male

Reported by a physician from United States on 2011-10-06

Patient: 7 year old male, weighing 30.4 kg (66.9 pounds)

Reactions: Completed Suicide, Abnormal Behaviour, Impulsive Behaviour, Aggression

Adverse event resulted in: death

Drug(s) suspected as cause:
Symbyax
    Dosage: 3mg/25mg (1 in 1 d),
    Indication: Aggression
    Start date: 2009-03-18
    End date: 2009-04-16

Symbyax
    Dosage: 3mg/25mg (1 in 1 d),
    Indication: Impulsive Behaviour
    Start date: 2009-03-18
    End date: 2009-04-16

Lexapro
    Dosage: 5 mg (5 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Anxiety
    Start date: 2009-02-03
    End date: 2009-03-18

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2009-03-31
    End date: 2009-04-16

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2009-03-31
    End date: 2009-04-16

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Affective Disorder
    Start date: 2008-12-09
    End date: 2009-03-30

Vyvanse
    Dosage: 30 mg (30 mg, 1 in 1 d), oral; 50 mg (50 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Attention Deficit / Hyperactivity Disorder
    Start date: 2008-12-09
    End date: 2009-03-30

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017